You are viewing the site in preview mode

Skip to content

Advertisement

  • Poster presentation
  • Open Access

Protective role of Mannose binding Lectin (MBL2) promoter haplotypes on TB infection in South Indian HIV-1 patients

  • 1,
  • 1,
  • 2 and
  • 1Email author
BMC Infectious Diseases201414 (Suppl 3) :P37

https://doi.org/10.1186/1471-2334-14-S3-P37

  • Published:

Keywords

  • Tuberculosis
  • Peripheral Blood Mononuclear Cell
  • Mannose
  • Protective Role
  • Mycobacterium Tuberculosis

Background

Mannose binding Lectin (MBL) mediates protection against infections by activating the complement system, but certain microorganisms may increase infectivity by exploiting this host defence system. Hence, the purpose of this study is to evaluate MBL genetic variants with the development of TB infection caused by Mycobacterium tuberculosis among HIV patients.

Methods

Blood samples from TB+ART+ and TB-ART+ (n=30) were collected. Genomic DNA was extracted from Peripheral Blood Mononuclear Cells (PBMC) using salting out procedure. MBL promoter haplotypes of -550 H/L and -221Y/X associated with high, medium and low (HY, LY and LX) secretion was assessed by PCR-SSP.

Results

The Promoter haplotype (LY/LX) associated with deficient MBL levels conferred a protective role to TB in our study population with a significant difference (Chi-square (X 2 ) =4.00; p<0.05).

Conclusion

In this study, we could observe MBL2 promoter haplotypes with low MBL secretion may play a protective role to intracellular mycobacterium infections like TB in HIV seropositive individuals.

Authors’ Affiliations

(1)
Department of Immunology, School of Biological Sciences, Madurai Kamaraj University, Madurai, 625021, India
(2)
ART Centre, Govt. Theni Medical College and Hospital, Theni, 625512, India

Copyright

© Pandian et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement